The practical difference for patients is that the two peptides are discussed through different biological frameworks
Key Characteristics TESAMORELIN PROFILE Formula: CHNOS Weight: 5135.9 g/mol CAS: 901758-09-6 Structure: 44 amino acid GHRH analog Receptor: GHRH receptor IPAMORELIN PROFILE Formula: CHNO Weight: 711.86 g/mol CAS: 170851-70-4 Structure: Pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH) Receptor: GHS-R1a BLEND PHYSICAL PROPERTIES Form: White to off-white lyophilized powder Solubility: Water-soluble Storage: Keep refrigerated 3646 F (28 C) Stability: Stable when properly stored
This interaction stimulates growth hormone release through distinct pathways, offering complementary mechanisms to those found in Sermorelin
The MYST families of HATs are initially called after their pioneer family members MOZ, Ybf2, Sas2, and Tip60
In animal models (and in vitro work), it has been shown to release GH without substantially raising other hormones like ACTH or cortisol, which means less off-target hormonal disturbance
Unlike conventional chemotherapy, which non-selectively kills rapidly dividing cells, targeted therapies aim to minimize harm to normal tissues by focusing on tumor-specific molecular alterations (e.g., HER2 amplification, ALK rearrangements)
